Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech Bull 3X Direxion (NY: LABU )

130.22 USD -6.96 (-5.07%)
Official Closing Price Updated: 4:43 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about S&P Biotech Bull 3X Direxion

< Previous 1 2 3 4 5 6 7 8 9 Next >
Implied LABU Analyst Target Price: $160
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Up Over 100% in 2020 and 15% in 2021, ‘LABU’ Isn’t Holding Back
The biotechnology industry isn’t backing down, with ETFs like the Direxion Daily S&P Biotech Bull 3x Shares (LABU) gaining over 15% to start the new year. More strength could be ahead as the global... 
Tags Biotechnology Global X leveraged & inverse channel
From ETF Trends
Analysts Expect LABU To Hit $150
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
5 Best-Performing Leveraged ETFs of December
Here are the five best-performing leveraged equity ETFs that have piled up handsome gains this month. These funds will continue to be investors’ darlings provided the sentiments remain bullish. 
Tags ETFs
From Blogs - TalkMarkets
5 Best-Performing Leveraged ETFs of Fourth Quarter
Here are some leveraged ETFs that gained more than 85% over the past three months. These funds will continue to be investors’ darlings provided the sentiments remain bullish. 
Tags ETFs
From Blogs - TalkMarkets
3 Direxion ETFs Top List of Best Leveraged Performers
Traders understand that when you add leverage to the mix, the results can be explosive gains, but on the flip side, it could be losses and a blown trading account. Yahoo Finance focused on top... 
Tags Leveraged & Inverse Channel LABU CHAU
From ETF Trends
Analysts Predict 28% Gains Ahead For The Holdings of LABU
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Noteworthy ETF Outflows: LABU, ACAD, XLRN, ADVM
Symbols mentioned in this story: LABU, ACAD, XLRN, ADVM Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Top Performing Leveraged/Inverse ETFs: 12/13/2020
These were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework. While the Direxion Daily S&P Biotech... 
From ETFdb
The Math Shows LABU Can Go To $117
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
LABU, BIIB, BTAI, BLUE: Large Outflows Detected at ETF
Symbols mentioned in this story: LABU, BIIB, BTAI, BLUE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Implied LABU Analyst Target Price: $102
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stock ETFs Trade Mixed Despite Encouraging Vaccine Developments
Stock indexes and ETFs are mixed on Wednesday, as investors contemplated sanguine news concerning a coronavirus vaccine. Stock indices are attempting to recover gains made on Monday, with the Dow Jones... 
Tags LABU Direxion Invesco
From ETF Trends
Notable ETF Outflow Detected - LABU, RDUS, RGNX, RIGL
Symbols mentioned in this story: LABU, RDUS, RGNX, RIGL Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Stock ETFs Rocket Upwards Amid Promising Virus Vaccine Data
Stock indexes and index ETFs underwent a historic surge Monday as investors sent stocks to record levels with major presidential and coronavirus vaccine headlines. Investors were elated over trial data... 
Tags IWD Election LABU
From ETF Trends
Analysts See 45% Upside For LABU
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Buy on the Dip Prospects: November 4 Edition
Here is a look at ETFs that currently offer attractive short buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be... 
From ETFdb
Heading into the Election, Traders Are Still Betting On Tech
If the first three quarters of 2020 have been any indication, the final three months of the year will more than likely hold its fair ... 
Tags Short Ideas SOXL Trading Ideas
From Benzinga
LABU, ACAD, ADVM, AGEN: ETF Outflow Alert
Symbols mentioned in this story: LABU, ACAD, ADVM, AGEN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Add Up The Pieces: LABU Could Be Worth $93
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Short Sellers Back Off From Biotech ETFs
The Covid-19 brought certain sectors serendipitous gains like technology, but even that space is now seeing sell-offs amid a September sell-off. As such, short sellers are coming in to reap the... 
Tags Leveraged & Inverse Channel LABU short seller
From ETF Trends
Top Performing Leveraged/Inverse ETFs: 09/20/2020
These were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework. Like their non-geared siblings,... 
From ETFdb
Notable ETF Inflow Detected - LABU, ACAD, ADVM, AGEN
Symbols mentioned in this story: LABU, ACAD, ADVM, AGEN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
How The Parts Add Up: LABU Targets $79
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
COVID Trade: The Race for an Ounce of Prevention
LABU: Which Biotechs Have Led the Covid Trade? Summertime is typically regarded as a notoriously choppy month for markets as volume tends to dissipate. But 2020 is obviously a year of altered... 
Tags Leveraged & Inverse Channel LABU
From ETF Trends
COVID Trade: The Race for an Ounce of Prevention
Summertime is typically regarded as a notoriously choppy month for markets as volume tends to dissipate. But 2020 is obviously a year of altered expectations. While volatility still permeates the broad... 
From ETFdb
Biotech Has Been in a Steady Uptrend Even Through Covid-19
It’s been a memorable, if not unusual, summer of 2020, but it’s not stopping biotech bulls from charging forward. The sector has been on a steady uptrend despite the economic effects of Covid-19.... 
Tags biotech Biotechnology Leveraged & Inverse Channel
From ETF Trends
Biotech Has Steadily Moved Up, Even Through Covid-19
It’s been a memorable, if not unusual, summer of 2020, but it’s not stopping biotech bulls from charging forward. The sector has been on a steady uptrend despite the economic effects of Covid-19. 
From ETFdb
Analysts Anticipate LABU Will Reach $83
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Buy on the Dip Prospects: August 12 Edition
Here is a look at ETFs that currently offer attractive short buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be... 
From ETFdb
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.